Vanda Pharmaceuticals (VNDA) Operating Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -22.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.41% |
| Dec 31, 2025 | -292.58% |
| Sep 30, 2025 | -184.40% |
| Jun 30, 2025 | -279.49% |
| Mar 31, 2025 | -344.27% |
| Dec 31, 2024 | -44.90% |
| Sep 30, 2024 | -83.49% |
| Jun 30, 2024 | -253.89% |
| Mar 31, 2024 | -560.83% |
| Dec 31, 2023 | -207.01% |
| Sep 30, 2023 | -253.40% |
| Jun 30, 2023 | -182.84% |
| Mar 31, 2023 | 126.13% |
| Dec 31, 2022 | -23.24% |
| Sep 30, 2022 | -63.88% |
| Jun 30, 2022 | -72.02% |
| Mar 31, 2022 | -174.16% |
| Dec 31, 2021 | -17.37% |
| Sep 30, 2021 | 39.74% |
| Jun 30, 2021 | 34.87% |
| Mar 31, 2021 | 8,372.80% |
| Dec 31, 2020 | 146.31% |
| Sep 30, 2020 | -28.04% |
| Jun 30, 2020 | -7.32% |
| Mar 31, 2020 | 94.01% |
| Dec 31, 2019 | -53.63% |
| Sep 30, 2019 | 72.61% |
| Jun 30, 2019 | 152.88% |
| Mar 31, 2019 | -185.46% |
| Dec 31, 2018 | 525.58% |
| Sep 30, 2018 | 226.61% |
| Jun 30, 2018 | 303.38% |
| Mar 31, 2018 | 130.89% |
| Dec 31, 2017 | -228.75% |
| Sep 30, 2017 | -653.91% |
| Jun 30, 2017 | 59.82% |
| Mar 31, 2017 | 36.63% |
| Dec 31, 2016 | 95.61% |
| Sep 30, 2016 | 93.16% |
| Jun 30, 2016 | 12.26% |
| Mar 31, 2016 | -21.20% |
| Dec 31, 2015 | -121.37% |
| Sep 30, 2015 | -558.91% |
| Jun 30, 2015 | 74.74% |
| Mar 31, 2015 | 61.27% |
| Dec 31, 2014 | 994.53% |
| Sep 30, 2014 | 73.34% |
| Jun 30, 2014 | -533.05% |
| Mar 31, 2014 | -482.21% |
| Dec 31, 2013 | -21.20% |
| Sep 30, 2013 | -0.67% |
| Jun 30, 2013 | 57.79% |
| Mar 31, 2013 | 45.11% |
| Dec 31, 2012 | -8.80% |
| Sep 30, 2012 | -63.83% |
| Jun 30, 2012 | -434.37% |
| Mar 31, 2012 | -118,914.29% |
| Dec 31, 2011 | -846.90% |
| Sep 30, 2011 | -543.20% |
| Jun 30, 2011 | -230.77% |